Case Reports in Infectious Diseases
Volume 2018 (2018), Article ID 5745708, 2 pages
https://doi.org/10.1155/2018/5745708

Case Report

A Case of Biliary Tract Infection Caused by KPC-2-Producing Kluyvera ascorbata

Lu Wang,1,2 Ying Jing,¹ Kaisheng Lai,¹ Jingna An,¹ and Jiyong Yang¹

¹Department of Microbiology, Chinese PLA General Hospital, Beijing, China
²Department of Clinical Laboratory, Lu’an People’s Hospital, Lu’an, Anhui, China

Correspondence should be addressed to Jiyong Yang; yangjy301@hotmail.com

Received 6 March 2018; Accepted 28 March 2018; Published 11 April 2018

Academic Editor: Paola Di Carlo

Copyright © 2018 Lu Wang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract.

Kluyvera spp. can cause various infections. However, carbapenemase-producing Kluyvera spp. has not been previously reported. We report a case of biliary tract infection caused by KPC-2-producing K. ascorbata in a 13-year-old female. To the best of our knowledge, this is the first report on infection caused by carbapenemase-producing Kluyvera spp.

1. Introduction

Kluyvera is a small, flagellated, motile gram-negative bacillus in the family of Enterobacteriaceae, which has been identified in the natural environment, and is part of the normal flora of human gastrointestinal tract [1]. Kluyvera genus consists of four species: K. ascorbata, K. cryocrescens, K. Georgiana, and K. cochleae. K. ascorbata can cause various infections including urinary tract infection (UTI), bacteremia, and severe sepsis [1–5]. Here, we report a case of biliary tract infection caused by KPC-2-producing K. ascorbata.

2. Case Report

The patient was a 13-year-old female with hepatoblastoma who underwent left third hepatectomy in August 2017. Two months after the operation, the patient was readmitted to the hospital for signs of progressive jaundice and fever. CT examination revealed the presence of prehepatic fluid inclusion in the patient and, percutaneous transhepatic cholangial drainage (PTCD) under B-scan ultrasonography was subsequently performed. After the procedure, the patient showed persistent fever with leukocyte increase. On November 24, K. ascorbata was isolated from the biliary drainage. Levofloxacin in combination with meropenem was used to treat the infection. However, the patient’s liver function continued to deteriorate with persistent fever. On December 10, the patient was discharged from the hospital for personal reasons.

The K. ascorbata isolate exhibited resistance to cephalosporins (ceftazidime, cefatriaxone, and cefepime) and carbapenems (imipenem and meropenem) with minimal inhibitory concentrations (MICs) of more than 64 mg/L and 16 mg/L, respectively. The carbapenem-resistant K. ascorbata isolate was screened for common carbapenemase genes (including blaIMP, blaVIM, blaOXA-48, blaNDM, and blaKPC) using PCR, and subsequent sequencing of amplicons was also performed. The K. ascorbata was confirmed to be a KPC-2-producing isolate.

3. Discussion

The Kluyvera genus was first named by a Dutch microbiologist Albert Jan Kluyver in 1936, and it consists of four species (K. ascorbata, K. cryocrescens, K. Georgiana, and K. cochleae). Since then, various infections caused by Kluyvera spp., including bacteremia, liver abscess, and urinary tract infection, have been reported worldwide [3]. In this case report, the patient suffered a biliary tract infection caused by K. ascorbata. Meropenem in combination with levofloxacin was used to treat the infection. However, the symptoms of the patient did not improve because of the resistance phenotype of the pathogen.

The K. ascorbata isolate from this patient was blaKPC-2 positive. As the most common carbapenemase, KPC-2 has been detected in K. ascorbata and K. Georgiana isolates from Israel and Brazil, respectively [6, 7]. Furthermore, polymyxin-resistance gene mcr-1 has also been found in K. ascorbata [8]. The Kluyvera spp. has been commonly regarded as avirulent and could serve as a reservoir of resistance genes, leading to dissemination of these genes among different species and the spread of resistant pathogens among patients and in the environment [7]. For example, the resistant gene carried by K. ascorbata (named KLUA) has been confirmed to be the progenitor of CTX-M which is thought to be the most common and important extended-spectrum β-lactamase gene [9, 10]. The KLUA-producing Kluyvera spp. can survive for a long time in the environment, such as swage and the human gut, and promote drug resistance gene transfer [11]. The KPC-2-producing K. ascorbata has only been isolated from a rectal surveillance in Israel [7], and in this report, it was isolated from the specimen of infected site for the first time. Furthermore, combined use of antibiotics did not improve clinical symptoms of the infected patient, suggesting the tendency and possibility of resistant Kluyvera spp. as the pathogen of various infections rather than just a reservoir of resistance genes.

In conclusion, due to the characteristics of fast and easy transmission of various resistance genes, strict monitoring and more research are need for the control and successful treatment of drug-resistant bacterial infection and the prevention of the rapid transmission of the drug resistance genes.

Conflicts of Interest

The authors declare that there are no conflicts of interest.

Acknowledgments

This work was supported by the Special Key Project of Biosafety Technologies (2017YFC1200803) for the National Key R&D Program of China.

References

J. E. Carter and T. N. Evans, “Clinically significant Kluyvera infections: a report of seven cases,” American Journal of Clinical Pathology, vol. 123, no. 3, pp. 334–338, 2005.

F. Ochi, H. Tauchi, M. Mizumoto, H. Miyamoto, and E. Ishii, “Kluyvera ascorbata infection in a neonate,” Pediatrics International, vol. 59, no. 5, pp. 640-641, 2017.

M. A. Alfreijat, “Case of urinary tract infection and severe sepsis caused by Kluyvera ascorbata in a 73-year-old female with a brief literature review,” Case Reports in Infectious Diseases, vol. 2017, Article ID 3848963, 2 pages, 2017.

D. Sharma, T. Dasi, S. Murki, and T. P. Oleti, “Kluyvera ascorbata sepsis in an extremely low birth weight infant,” Indian Journal of Medical Microbiology, vol. 33, no. 3, pp. 437–439, 2015.

S. Moonah, K. Deonarine, and C. Freeman, “Multidrug resistant Kluyvera ascorbata septicemia in an adult patient: a case report,” Journal of Medical Case Reports, vol. 4, no. 1, p. 197, 2010.

V. B. Ribeiro, A. P. Zavascki, C. S. Nodari et al., “Detection of blaKPC-2 in a carbapenem-resistant Kluyvera georgiana,” Journal of Antimicrobial Chemotherapy, vol. 67, no. 11, pp. 2776-2777, 2012.

Y. Geffen, A. Adler, S. Paikin et al., “Detection of the plasmid-mediated KPC-2 carbapenem-hydrolysing enzyme in three unusual species of the Enterobacteriaceae family in Israel,” Journal of Antimicrobial Chemotherapy, vol. 68, no. 3, pp. 719-720, 2013.

F. Zhao and Z. Zong, “Kluyvera ascorbata strain from hospital sewage carrying the mcr-1 colistin resistance gene,” Antimicrobial Agents and Chemotherapy, vol. 60, no. 12, pp. 7498–7501, 2016.

C. Humeniuk, G. Arlet, V. Gautier, P. Grimont, R. Labia, and A. Philippon, “Beta-lactamases of Kluyvera ascorbata, probable progenitors of some plasmid-encoded CTX-M types,” Antimicrobial Agents & Chemotherapy, vol. 46, no. 9, pp. 3045–3049, 2002.

M. M. Rodríguez, P. Power, M. Radice et al., “Chromosome-encoded CTX-M-3 from Kluyvera ascorbata: a possible origin of plasmid-borne CTX-M-1-derived cefotaximases,” Antimicrobial Agents & Chemotherapy, vol. 48, no. 12, pp. 4895–4897, 2004.

J. J. Farmer, G. R. Fanning, G. P. Huntleycarter et al., “Kluyvera, a new (redefined) genus in the family Enterobacteriaceae: identification of Kluyvera ascorbata sp. nov. and Kluyvera cryocrescens sp. nov. in clinical specimens,” Journal of Clinical Microbiology, vol. 13, no. 5, pp. 919–933, 1981.